...
首页> 外文期刊>Molecular syndromology >Fibrodysplasia Ossificans Progressiva: Clinical Course, Genetic Mutations and Genotype-Phenotype Correlation
【24h】

Fibrodysplasia Ossificans Progressiva: Clinical Course, Genetic Mutations and Genotype-Phenotype Correlation

机译:骨化性增生:临床过程,遗传突变和基因型-表型相关性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Fibrodysplasia ossificans progressiva (FOP, MIM 135100) is a rare autosomal dominant genetic disorder and the most disabling condition of heterotopic (extraskeletal) ossification in humans. Mutations in the ACVR1 gene (MIM 102576) were identified as a genetic cause of FOP [Shore et al., 2006]. Most patients with FOP have the same recurrent single nucleotide change c.617G>A, p.R206H in the ACVR1 gene. Furthermore, 11 other mutations in the ACVR1 gene have been described as a cause of FOP. Here, we review phenotypic and molecular findings of 130 cases of FOP reported in the literature from 1982 to April 2014 and discuss possible genotype-phenotype correlations in FOP patients.
机译:进行性骨增生性纤维增生症(FOP,MIM 135100)是一种罕见的常染色体显性遗传疾病,是人类异位(骨骼外)骨化的最致残条件。 ACVR1基因(MIM 102576)中的突变被鉴定为FOP的遗传原因[Shore等,2006]。大多数患有FOP的患者在ACVR1基因中具有相同的复发性单核苷酸改变c.617G> A,p.R206H。此外,ACVR1基因中的其他11个突变已被描述为导致FOP的原因。在这里,我们回顾了1982年至2014年4月文献报道的130例FOP的表型和分子发现,并讨论了FOP患者可能的基因型与表型相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号